Correlation Between NYSE Composite and Aequus Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Aequus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Aequus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NYSE Composite and Aequus Pharmaceuticals, you can compare the effects of market volatilities on NYSE Composite and Aequus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Aequus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Aequus Pharmaceuticals.

Diversification Opportunities for NYSE Composite and Aequus Pharmaceuticals

-0.71

Correlation Coefficient

NYSE Composite  Aequus Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between NYSE and Aequus is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Aequus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aequus Pharmaceuticals and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Aequus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aequus Pharmaceuticals has no effect on the direction of NYSE Composite i.e., NYSE Composite and Aequus Pharmaceuticals go up and down completely randomly.

Pair Corralation between NYSE Composite and Aequus Pharmaceuticals

Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.06 times more return on investment than Aequus Pharmaceuticals. However, NYSE Composite is 15.75 times less risky than Aequus Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Aequus Pharmaceuticals is currently generating about -0.09 per unit of risk. If you would invest  1,925,638  in NYSE Composite on September 15, 2024 and sell it today you would earn a total of  47,299  from holding NYSE Composite or generate 2.46% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	98.46%
Values	Daily Returns

NYSE Composite  vs.  Aequus Pharmaceuticals

Pair Trading with NYSE Composite and Aequus Pharmaceuticals

The main advantage of trading using opposite NYSE Composite and Aequus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Aequus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aequus Pharmaceuticals will offset losses from the drop in Aequus Pharmaceuticals' long position.

The idea behind NYSE Composite and Aequus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.